100 related articles for article (PubMed ID: 27081789)
1. Knockdown of Rhotekin 2 expression suppresses proliferation and invasion and induces apoptosis in hepatocellular carcinoma cells.
Wei W; Chen H; Liu S
Mol Med Rep; 2016 Jun; 13(6):4865-71. PubMed ID: 27081789
[TBL] [Abstract][Full Text] [Related]
2. Knockdown by shRNA identifies SLC44A5 as a potential therapeutic target in hepatocellular carcinoma.
Peng GZ; Ye QF; Wang R; Li MX; Yang ZX
Mol Med Rep; 2016 Jun; 13(6):4845-52. PubMed ID: 27082540
[TBL] [Abstract][Full Text] [Related]
3. Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.
Liao YX; Zeng JM; Zhou JJ; Yang GH; Ding K; Zhang XJ
Mol Med Rep; 2016 Jun; 13(6):4872-8. PubMed ID: 27082503
[TBL] [Abstract][Full Text] [Related]
4. Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046-miR-1299-RTKN2 ceRNA pathway.
Zhang L; He S; Guan H; Zhao Y; Zhang D
J Viral Hepat; 2023 Oct; 30(10):819-829. PubMed ID: 37421213
[TBL] [Abstract][Full Text] [Related]
5. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
6. Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells.
Wang X; Zhang L; Wang W; Wang Y; Chen Y; Xie R; Li X; Wang Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30389712
[TBL] [Abstract][Full Text] [Related]
7. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.
Zhou J; Zhang Y; Qi Y; Yu D; Shao Q; Liang J
Oncol Rep; 2017 Feb; 37(2):1227-1234. PubMed ID: 27922690
[TBL] [Abstract][Full Text] [Related]
9. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells.
Pang X; Li R; Shi D; Pan X; Ma C; Zhang G; Mu C; Chen W
Oncol Lett; 2017 Dec; 14(6):8028-8034. PubMed ID: 29250187
[TBL] [Abstract][Full Text] [Related]
12. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
Zhang D; Liu J; Wang Y; Chen J; Chen T
J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
[TBL] [Abstract][Full Text] [Related]
13. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation.
Yao Z; Hu K; Huang H; Xu S; Wang Q; Zhang P; Yang P; Liu B
Int J Mol Med; 2015 Nov; 36(5):1393-9. PubMed ID: 26397132
[TBL] [Abstract][Full Text] [Related]
14. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
15. Effects of short interfering RNA-mediated gene silencing of SKA1 on proliferation of hepatocellular carcinoma cells.
Qin X; Yuan B; Xu X; Huang H; Liu Y
Scand J Gastroenterol; 2013 Nov; 48(11):1324-32. PubMed ID: 24010405
[TBL] [Abstract][Full Text] [Related]
16. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PPP5C inhibits growth of hepatocellular carcinoma cells in vitro.
Feng L; Sun P; Li Z; Liu M; Sun S
Appl Biochem Biotechnol; 2015 Jan; 175(1):526-34. PubMed ID: 25326185
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
Cheng Q; Cao X; Yuan F; Li G; Tong T
Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Wang G; Wei Z; Jia H; Zhao W; Yang G; Zhao H
Oncol Rep; 2015 Sep; 34(3):1121-8. PubMed ID: 26151573
[TBL] [Abstract][Full Text] [Related]
20. Small nucleolar RNA U2_19 promotes hepatocellular carcinoma progression by regulating Wnt/β-catenin signaling.
Wang H; Ma P; Liu P; Chen B; Liu Z
Biochem Biophys Res Commun; 2018 Jun; 500(2):351-356. PubMed ID: 29654759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
